Healthcare status of adults with pulmonary hypertension due to congenital heart disease

被引:1
|
作者
Busse, Amely J. [1 ,2 ]
Freilinger, Sebastian [1 ,3 ,4 ]
Eicken, Andreas [1 ]
Ewert, Peter [1 ]
Freiberger, Annika [1 ]
Huntgeburth, Michael [1 ]
Nagdyman, Nicole [1 ]
von Scheidt, Fabian [1 ]
Kaemmerer, Harald [1 ]
Weyand, Michael [2 ]
机构
[1] Tech Univ Munich, German Heart Ctr Munich, Clin Congenital Heart Dis & Pediat Cardiol, Munich, Germany
[2] Friedrich Alexander Univ, Univ Hosp Erlangen, Dept Cardiac Surg, Erlangen, Germany
[3] Tech Univ Munich, Dept Sport & Hlth Sci, Prevent Pediat, Munich, Germany
[4] German Heart Ctr Munich, Clin Congenital Heart Dis & Pediat Cardiol, Lazarettstr 36, D-80336 Munich, Germany
关键词
Congenital heart defects; pulmonary hypertension (PH); healthcare status; counselling needs; CHD; ARTERIAL-HYPERTENSION; SEPTAL-DEFECT;
D O I
10.21037/cdt-22-281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In the long-term course of treated and untreated congenital heart defects (CHD), pulmonary hypertension (PH) is one of the most relevant complications. Since PH carries a high risk for mortality and morbidity, it is important to improve the status of healthcare and medical knowledge regarding the affected patients. Therefore, this study aimed to determine the current medical care status, health-related knowledge, and specific counseling needs of adults with various forms of CHD (ACHD) who are at increased risk of developing PH, as well as those with manifest PH. Methods: In this retrospective cross-sectional study, a representative sample of 803 ACHD were analyzed. Patients were split into three groups based on CHD: low risk for PH, at risk for pre- or post-capillary PH, and manifest PH. Data collection took place between September 2017 until February 2018 in a tertiary care center for ACHD. Healthcare status and specific needs for information or advice were analyzed using a questionnaire designed by our group. The state of knowledge of the patients was assessed by comparing this questionnaire and the corresponding medical records. Results: Both patients with manifest PH (n=51) and patients at risk to develop PH (n=629) were insufficiently informed about their health status, specific care structures available to them, and patient organizations. About 50% of the patients had specific counseling needs, especially regarding physical capability and sports, daily stress, rehabilitation measures, and pregnancy. Only 47.8% of patients with manifest PH were aware of suffering from PH (P<0.001). In particular, the patients had large knowledge deficits regarding comorbidities related to their health condition. Conclusions: PH is a quantitatively and qualitatively underestimated residuum or sequela of CHD that significantly affects outcome and prognosis in ACHD. Multidisciplinary, structured, and specific counseling of affected individuals with corresponding risk constellations is urgently needed. A prerequisite for this is closer collaboration between primary care physicians (PCPs), such as general practitioners, family physicians, internists, or general cardiologists, and ACHD specialists. Targeted patient counseling and care could have a positive impact on the level of awareness of those affected and favorably influence their prognosis.
引用
收藏
页码:840 / +
页数:17
相关论文
共 50 条
  • [11] Pulmonary Hypertension Due to Left Heart Disease
    Guazzi, Marco
    Borlaug, Barry A.
    CIRCULATION, 2012, 126 (08) : 975 - 990
  • [12] Bodily isomerism is an independent risk factor for pulmonary hypertension in adults with congenital heart disease
    Loomba, Rohit S.
    Aggarwal, Saurabh
    Arora, Rohit R.
    Anderson, Robert
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (03) : 194 - 199
  • [13] Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease
    Menachem, Jonathan N.
    Birati, Edo Y.
    Zamani, Payman
    Owens, Anjali T.
    Atluri, Pavan
    Bermudez, Christian A.
    Drajpuch, David
    Fuller, Stephanie
    Kim, Yuli Y.
    Mascio, Christopher E.
    Palanivel, Vikram
    Rame, J. Eduardo
    Wald, Joyce
    Acker, Michael A.
    Mazurek, Jeremy A.
    CONGENITAL HEART DISEASE, 2018, 13 (04) : 492 - 498
  • [14] Pulmonary hypertension associated with congenital heart disease; clinical decision scenario
    Alakhfash, Ali A.
    Alqwaiee, Abdullah
    Alakhfash, Ghadeer Ali
    Alhajjaj, Athkar
    Almesned, Abdulrahman A.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [15] Inflammation and Congenital Heart Disease Associated Pulmonary Hypertension
    Gursoy, Mete
    Salihoglu, Ece
    Hatemi, Ali Can
    Hokenek, A. Faruk
    Ozkan, Suleyman
    Ceyran, Hakan
    HEART SURGERY FORUM, 2015, 18 (01) : E38 - E41
  • [16] Congenital Heart Disease-Associated Pulmonary Hypertension
    Rosenzweig, Erika B.
    Krishnan, Usha
    CLINICS IN CHEST MEDICINE, 2021, 42 (01) : 9 - 18
  • [17] Treatment of pulmonary hypertension associated with congenital heart disease
    Apitz, C.
    MONATSSCHRIFT KINDERHEILKUNDE, 2017, 165 (11) : 972 - 981
  • [18] Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry
    Skride, Andris
    Sablinskis, Kristaps
    Lejnieks, Aivars
    Rudzitis, Ainars
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 36 : E20 - E21
  • [19] Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies
    D'Alto, Michele
    Diller, Gerhard-Paul
    HEART, 2014, 100 (17) : 1322 - 1328
  • [20] Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era
    Wals-Rodriguez, Amadeo-Jose
    Rodriguez-Puras, Maria-Jose
    Garcia-Orta, Rocio
    Robledo, Juan
    Moreno, Eduardo
    Federero, Carmen
    Camacho, Rocio
    Manso, Begona
    Hernandez, Nuria
    Cubero, Jose Maria
    Abia, Raquel Ladron
    Ramos, Pilar Cejudo
    Ordonez, Antonio
    Gallego, Pastora
    HEART & LUNG, 2022, 51 : 75 - 81